Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Digital twins could revolutionize diabetes care

NCT ID NCT07650682

First seen Jun 22, 2026 · Last updated Jun 22, 2026

Summary

This observational study is collecting detailed metabolic data from 25 adults with insulin-dependent type 2 diabetes. Participants will have frequent blood tests after a meal and wear glucose monitors and activity trackers at home. The goal is to create mathematical models, or 'digital twins,' that could help researchers better understand how the body responds to food, exercise, and diabetes treatments, potentially paving the way for personalized therapies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Illinois Institute of Technology

    RECRUITING

    Chicago, Illinois, 60616, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help researchers create personalized digital models of diabetes, potentially leading to better treatments and technologies in the future.

What could go wrong

This is a small observational study (25 people) focused on data collection, not testing a treatment. The models may not translate into real-world benefits for years, if at all.

Conditions

The condition(s) this trial relates to.

Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.